Naik, Vaishnavi, et al. “Emerging Role of SGLT2 Inhibitors Beyond Glycemic Control: ‘Cardiovascular and Renal Benefits and Risks’”. Cardiovascular Disease Prevention and Control, vol. 1, no. 1, Mar. 2026, pp. 29-38, https://doi.org/10.64229/v3v43h95.